Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16597528 | 0.92 | SRC (0.36) | SRCL3MBTL1TDP1PKMALDH1A1 | |
| SCHEMBL13430898 | 0.92 | CA1 (0.46) | L3MBTL1MEN1KMT2A | |
| SCHEMBL19904731 | 0.92 | MEN1 (0.45) | L3MBTL1PKMALDH1A1MEN1KMT2A | |
| SCHEMBL13430907 | 0.91 | BTN3A1 (0.41) | SRCL3MBTL1TDP1PKMMEN1 | |
| SCHEMBL13430901 | 0.90 | CYP3A4 (0.43) | — | |
| SCHEMBL16581628 | 0.89 | LPAR3 (0.47) | SRCL3MBTL1PKMALDH1A1 | |
| SCHEMBL13430900 | 0.89 | ANPEP (0.39) | SRCL3MBTL1PKMMEN1KMT2A | |
| SCHEMBL16588477 | 0.87 | LPAR3 (0.50) | SRCL3MBTL1PKMALDH1A1 | |
| SCHEMBL13430906 | 0.87 | L3MBTL1 (0.38) | SRCL3MBTL1PKMALDH1A1MEN1 | |
| SCHEMBL3860027 | 0.82 | SRC (0.44) | SRCL3MBTL1TDP1PKMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3049502-B1 | LONG-TERM STABLE PHOTOACTIVE COMPOSITION, SUCH AS PHOSPHORESCENT COMPOSITION OR TTA-PHOTON UPCONVERSION COMPOSITION | MAX PLANCK GESELLSCHAFT (DE) | 2020-04-01 | — | — | EP | disclosed |
| US-10400164-B2 | Long-term stable photoactive composition, such as phosphorescent composition or TTA-photon upconversion composition | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2019-09-03 | — | — | US | disclosed |
| US-20160222286-A1 | LONG-TERM STABLE PHOTOACTIVE COMPOSITION, SUCH AS PHOSPHORESCENT COMPOSITION OR TTA-PHOTON UPCONVERSION COMPOSITION | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2016-08-04 | — | — | US | disclosed |
| US-20160222286-A1 | LONG-TERM STABLE PHOTOACTIVE COMPOSITION, SUCH AS PHOSPHORESCENT COMPOSITION OR TTA-PHOTON UPCONVERSION COMPOSITION | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2016-08-04 | — | — | US | disclosed |
| WO-2015044129-A1 | LONG-TERM STABLE PHOTOACTIVE COMPOSITION, SUCH AS PHOSPHORESCENT COMPOSITION OR TTA-PHOTON UPCONVERSION COMPOSITION | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-04-02 | — | — | WO | disclosed |
| EP-2851407-A1 | Long-term stable photoactive composition, such as phosphorescent composition or TTA-photon upconversion composition | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10400164-B2 | Long-term stable photoactive composition, such as phosphorescent composition or TTA-photon upconversion composition | TTPA, TCP1, TERB1 | SRC 2812/4885L3MBTL1 1299/4885TDP1 732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.